Drug Shortage Report for APO-DORZO-TIMOP
Report ID | 185036 |
Drug Identification Number | 02299615 |
Brand name | APO-DORZO-TIMOP |
Common or Proper name | DORZOLAMIDE/TIMOLOL |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | TIMOLOL DORZOLAMIDE |
Strength(s) | 5MG 20MG |
Dosage form(s) | SOLUTION SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 10 ML |
ATC code | S01ED |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-02-14 |
Estimated end date | 2023-03-03 |
Actual end date | 2023-02-22 |
Shortage status | Resolved |
Updated date | 2023-02-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-02-23 | French | Compare |
v3 | 2023-02-23 | English | Compare |
v2 | 2023-02-16 | French | Compare |
v1 | 2023-02-16 | English | Compare |
Showing 1 to 4 of 4